Skip to content

Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort

Randomized Trial to Determine the Effect of Dorsal Penile Block on Post-Robotic Prostatectomy Foley Discomfort

Status
Withdrawn
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01565512
Enrollment
0
Registered
2012-03-28
Start date
2011-11-30
Completion date
2014-07-31
Last updated
2015-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foley Catheter Discomfort, Prostate Cancer, Robotic Prostatectomy

Keywords

randomized trial, robotic prostatectomy, prostate cancer, foley catheter discomfort

Brief summary

The indwelling urethral foley is a major source of discomfort following radical prostatectomy. Our hypothesis is that intra-operative dorsal penile nerve block with bupivacaine may decrease immediate post-operative foley discomfort.

Detailed description

Patients undergoing robot-assisted radical prostatectomy (RARP) will be randomized in a double-blind placebo controlled manner to undergo penile ring block injection at the time of skin incision closure. A visual analog scale (VAS) based questionnaire including newly developed foley discomfort scores will be administered at various time points post-operatively.

Interventions

DRUGBupivacaine

A total of 100 mg bupivacaine (20 mL of 5 mg/mL solution) administered once by subcutaneous injection while patient is under general anesthesia at end of operation.

DRUGSaline

A total of 20 mL on injectable saline(0.9% NS) administered once by subcutaneous injection while patient is under general anesthesia at end of operation.

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age 40 years and above, * diagnosis of prostate cancer, * electing to undergo robot-assisted radical prostatectomy

Exclusion criteria

* allergy to bupivacaine or amide-type local anesthetics, * chronic pain condition, * recently or currently on narcotics, * genital abnormalities

Design outcomes

Primary

MeasureTime frame
Prevalence of pain/discomfortpostoperative

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026